Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

Published Date: 15 Nov 2024

Better OS, PFS, response rate, but newer combination strategies not included

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A specific drug combination is being tested in a clinical trial for the deadly brain cancer glioblastoma.

2.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

3.

Cancerous breast tissue glows in new AI-enhanced MRI images

4.

Study finds common genetic target may halt breast cancer cell growth

5.

Pickleball program boosts health and wellness for cancer survivors, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot